BioCentury
ARTICLE | Product Development

Emerging COVID-19 serology tests aim for neutralizing antibodies

New COVID-19 serology tests focus on the antibodies believed most likely to block viral entry

June 11, 2020 5:29 PM UTC

The next wave of serology tests from big diagnostic players could get closer to telling people whether they are protected from COVID-19 by homing in on the antibodies most likely to block viral entry into cells. The new entrants highlight how far industry remains from defining ideal tests for COVID-19 exposure and immunity.

FDA has granted 15 developers Emergency Use Authorization (EUA) for COVID-19 serology tests, which detect antibodies against SARS-CoV-2 in a patient’s blood, a sign that he or she has encountered the virus and mounted some degree of immune response. ...



Access The Full Article